Rafael Esteban - Concepedia

Author

Rafael Esteban

Vall d'Hebron Hospital Universitari ORCID

Also Known As

Ana Barreira, Antonio Gonzlez, Esteban R, Esteban, R., Esteban, Rafael, Esteban-Mur, Rafael, Georgios Kalambokis, I Fuentes, I. Deary, J ESTEBAN

715

Publications

26K

Citations

H-Index

139

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Instituto de Salud Carlos III Vall d'Hebron Institut de Recerca

About

Rafael Esteban is an author at Vall d'Hebron Hospital Universitari specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	117	10K
2	Public Health	13	17	1.2K
3	Health Sciences	11	13	1.4K
4	Natural Sciences	1	1	20
5	Social Sciences	1	1	86

Rafael Esteban

238

Publications

21.2K

Citations

H-Index

Page 1

	Year	Citations
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz, New England Journal of Medicine	2011	1.6K
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C Gary L. Davis, Rafael Esteban, Vinod K. Rustgi, New England Journal of Medicine	1998	1.3K
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution Marı́a Martell, Juan Ignacio Esteban, Josep Quer, Journal of Virology Viral DiagnosticsHepatitis C VirusGeneticsHcv GenomesRelated Genomes	1992	930
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN L. Viladomiu, Antonio González, M Roget, The Lancet VaccinationVirus EpidemiologyHepatitis CViral HepatitisHepatitis	1989	900
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 Stefan Zeuzem, Geoffrey Dusheiko, Riina Salupere, New England Journal of Medicine	2014	796
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski, Gastroenterology Viral PersistenceHepatologyHepatitis CViral KineticsViral Hepatitis	2010	723
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy George Papatheodoridis, George Ν. Dalekos, Vana Sypsa, Journal of Hepatology Hepatitis DHepatologyViral HepatitisMedicineHepatitis B	2015	518
Normal protein diet for episodic hepatic encephalopathy: results of a randomized study Juan Córdoba, M. Planas, Francesc Sanpedro, Journal of Hepatology Episodic Hepatic EncephalopathyNutritionHepatologyLiver PhysiologyClinical Nutrition	2004	468
Global surveillance and control of hepatitis C Daniel Lavanchy, R H Purcell, F. Blaine Hollinger, UCL Discovery (University College London) VaccinationHepatitis CViral HepatitisGlobal HealthInternational Health	1999	434
Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis Juan Ignacio Esteban, Antonio González, José M. Hernández, New England Journal of Medicine	1990	387

Page 1